Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on January 24th, 2023%
The first participants are enrolled in a clinical trial of an implanted bio-feedback device to help women control urinary incontinence, sudden or stress-related urges to urinate. . . . → Read More: Trial Underway Testing Bioelectronic Incontinence Device
By Alan, on January 18th, 2023%
A biotechnology company creating products for gut health and a university immunology lab are evaluating cleaning products for potential damage to human protective tissues. . . . → Read More: Biotech, Academic Lab Partner on Microbiome-Safe Products
By Alan, on January 16th, 2023%
A vaccine against gonorrhea given as a nasal spray is shown to generate protective immune responses in lab mice of both sexes, and in females similar to an intravaginal vaccine. . . . → Read More: Nasal Spray Vaccine Shown to Stop Gonorrhea Infections
By Alan, on January 12th, 2023%
An international health organization is evaluating a new type of vaccine made with biodegradable RNA nanoparticles to help head off future viral pandemics. . . . → Read More: CEPI Assessing Advanced RNA Nanoparticle Vaccine
By Alan, on January 11th, 2023%
A new company developing techniques to analyze internal physiological sounds captured by stethoscopes as health indicators is raising $3.7 million in seed funds. . . . → Read More: Audio Digital Biomarkers Start-Up Raises $3.7M in Seed Funds
By Alan, on January 6th, 2023%
The biotechnology company BioNTech SE is partnering with the U.K. government to provide up to 10,000 personalized cancer immunotherapy treatments by 2030. . . . → Read More: BioNTech to Provide Personal Cancer Immunotherapies in UK
By Alan, on December 30th, 2022%
A new enterprise is formed to develop gene-editing therapies for mitochondrial disorders, rare inherited mutations in the energy centers of cells. . . . → Read More: Company Started for Gene Editing Rare Inherited Diseases
By Alan, on December 23rd, 2022%
A new company creating protein ingredients for food products from carbon dioxide converted by engineered bacteria is raising €4 million more in seed funds. . . . → Read More: Food Protein Biotech Adds €4M in Seed Funds
By Alan, on December 5th, 2022%
A clinical trial is underway testing a mobile app designed to help people with a serious lung disorder manage anxiety that often accompanies the disease. . . . → Read More: Trial Begins Testing Digital Therapy for Anxiety with Lung Disease
By Alan, on November 28th, 2022%
A new company developing DNA as a data storage medium with sustainable processes is raising €5 million ($US 5.22 million) in seed funding. . . . → Read More: DNA Storage Start-Up Gains €5M in Seed Funds
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|